Showing results (391-400 of 408) with videos related to
Sort By:
Pageof 41
The International Journal on Drug Policy|June 19, 2017
Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: The ACTIVATE studyJason Grebely, Olav Dalgard, Evan B Cunningham, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 16, 2023
Patient-Reported Outcomes During and After Hepatitis C Virus Direct-Acting Antiviral Treatment Among People Who Inject DrugsQinglu Cheng, Evan B Cunningham, Sophy Shih, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 14, 2019
Patterns of Drug and Alcohol Use and Injection Equipment Sharing Among People With Recent Injecting Drug Use or Receiving Opioid Agonist Treatment During and Following Hepatitis C Virus Treatment With Direct-acting Antiviral Therapies: An International StudyAndreea A Artenie, Evan B Cunningham, Gregory J Dore, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2019
Adherence to Once-daily and Twice-daily Direct-acting Antiviral Therapy for Hepatitis C Infection Among People With Recent Injection Drug Use or Current Opioid Agonist TherapyEvan B Cunningham, Behzad Hajarizadeh, Janaki Amin, et al.Journal of Burn Care & Research : Official Publication of the American Burn Association|May 18, 2018
Burn Surgeon and Palliative Care Physician Attitudes Regarding Goals of Care Delineation for Burned Geriatric PatientsHolly B Cunningham, Shannon A Scielzo, Paul A Nakonezny, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 14, 2020
Reinfection Following Successful Direct-acting Antiviral Therapy for Hepatitis C Virus Infection Among People Who Inject DrugsEvan B Cunningham, Behzad Hajarizadeh, Janaki Amin, et al.The American Journal of Hospice & Palliative Care|January 8, 2019
Trauma Surgeon and Palliative Care Physician Attitudes Regarding Goals-of-Care Delineation for Injured Geriatric PatientsHolly B Cunningham, Shannon A Scielzo, Paul A Nakonezny, et al.BMC Infectious Diseases|June 15, 2017
Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE studyEvan B Cunningham, Behzad Hajarizadeh, Olav Dalgard, et al.The International Journal on Drug Policy|January 6, 2026
Interventions to improve testing, linkage to care, and treatment for hepatitis C infection in prison: a systematic review and meta-analysisEvan B Cunningham, Alice Wheeler, Behzad Hajarizadeh, et al.JHEP Reports : Innovation in Hepatology|April 18, 2022
Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antiviralsAnita Y M Howe, Chaturaka Rodrigo, Evan B Cunningham, et al.Pageof 41